Clinical Trial Details

Trial ID: L0543
Source ID: IRCT2016061228411N1
Associated Drug: Cichorium
Title: Evaluation of the effects of Cichorium intybus seed on treatment of nonalcoholic fatty liver disease,a randomized double_blind clinical trial
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: non-alcoholic fatty liver disease. <br>Fatty (change of) liver, not elsewhere classified;Fatty (change of) liver, not elsewhere classified
Interventions: Intervention 1: Intervention group: Cichorium intybus seed syrup,8cc bid. Intervention 2: Control group: standardized placebo 8 cc bid.;Treatment - Drugs;Placebo;Intervention group: Cichorium intybus seed syrup,8cc bid;Control group: standardized plac
Outcome Measures: ALT. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: photometric.;AST. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: photometric.;FBS. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: Fasting blood glucose concentrations.;Triglisirid. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: blood test.;Cholestrol. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: blood test.;LDL. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: blood test.;HDL. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: blood test.;BMI. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: weight with kilograms on a scale,height with meters with the use of a rubber meter.;The severity of fatty liver. Timepoint: before intervention, 1 and 2 months after intervention. Method of measurement: ultrasound.nan
Sponsor/Collaborators: Research Vice chancellor of Zanjan University of Medical Science
Gender: All
Age: 20 years45 years
Phases: Phase 2
Enrollment: 60
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 31/05/2017
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/23063